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Abstract
Antigen-specific antibody responses against a model antigen (the B subunit of the heat labile toxin of enterotoxigenic
Escherichia coli, LTB) were studied in sheep following oral immunisation with plant-made and delivered vaccines. Delivery
from a root-based vehicle resulted in antigen-specific immune responses in mucosal secretions of the abomasum and small
intestine and mesenteric lymph nodes. Immune responses from the corresponding leaf-based vaccine were more robust
and included stimulation of antigen-specific antibodies in mucosal secretions of the abomasum. These findings suggest that
oral delivery of a plant bioencapsulated antigen can survive passage through the rumen to elicit mucosal and systemic
immune responses in sheep. Moreover, the plant tissue used as the vaccine delivery vehicle affects the magnitude of these
responses.
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Introduction
Vaccines administered via mucosal routes are sought-after
because they can induce both mucosal and systemic immune
responses to protect against infections caused by pathogens
entering and colonising mucosal surfaces such as the gastrointes-
tinal tract (GIT). Mucosal, humoral responses are characterised by
secretory antibodies of which the IgA isotype is the most
prominent and IgG less abundant [1,2]. An effective mucosal
vaccine must deliver antigen to mucosal inductive sites including
the mucosal lymphoid tissue (MALT) or sub-epithelial dendritic
cells (DCs) when MALT is absent [1,2]. Activated DCs then
transport the antigen via the lymphatics to draining mesenteric
lymph nodes (MLN) where antigen is presented and a specific
immune response mounted. Unfortunately, mucosal immune
responses are often variable, particularly when vaccines are
delivered orally, exposing the antigen to likely enzymatic
degradation in the acidic gastric environment [3]. Vaccine
delivery from plant tissues may overcome or at the very least
mitigate the hostile gastric environment. Evidence points to
antigens bioencapsulated within a plant cell being better protected
from the enzymatic degradation of the GIT, prolonging release
and presentation of the intact antigen to immune responsive sites
of the gut associated lymphoid tissues (GALT) [3]. In addition,
plant-made vaccines have a reduced risk of contamination with
animal pathogens [4,5] and are stable at room temperature when
stored as seed or freeze-dried material thus reducing the reliance
for a cold chain [6,7].
The heat labile toxin (LT) of enterotoxigenic Escherichia coli is
a well characterised, mucosal antigen often used as an adjuvant
[8,9] or carrier protein [10]. LT comprises a single, active ADP-
ribosylation subunit (LTA) and a non-toxic, pentameric subunit
(LTB) [11,12] that selectively binds GM1 ganglioside receptors in
the mucosal epithelium of the GIT [13,14]. LTB is stable in the
hostile environment of the GIT [15], can be produced in
transgenic plants and elicits potent antigen-specific immune
responses when delivered orally from various plant tissues
[3,10,16,17,18,19,20]. As such, LTB was chosen as a model
antigen to study immunogenicity of orally delivered plant-made
vaccines in ruminant species.
In an earlier study we examined different plant tissues as
potential vehicles for oral delivery of recombinant LTB (rLTB) in
the mouse GIT [3]. Our findings indicated that the plant tissue
type used as the vaccine delivery vehicle affected the timing of
antigen release, occurring earlier when delivered from leaf whilst
being delayed from root [3]. In this same study, the orally
delivered plant-made vaccines produced more robust immune
responses when formulated in a lipid (oil) based, rather than an
aqueous based medium [3]. On the basis of these preliminary
studies in mice, the aim of the present study was to determine
whether orally delivered plant-made vaccines survive passage
through the more complex ruminant digestive system and induce
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immune responses in sheep. Leaf- and root-based LTB vaccines,
each formulated in a lipid matrix, were compared and antigen-
specific antibody responses localised to specific sites in the sheep
GIT and mucosal immune system.
Materials and Methods
Plant materials
Hairy root cultures of transgenic Petunia parodii (petunia) plants
producing rLTB were generated and maintained as described
previously [3,21]. Control petunia hairy root cultures were stably
transformed with the pBinPlus empty vector [21,22]. For vaccine
batch processing, hairy root cultures were harvested 22 days after
subculture, snap frozen in liquid N2 then freeze-dried using
a Dynavac freeze drier (Model FD12) for 48 h with a maximum
shelf temperature of 20uC. Nicotiana benthamiana leaves transiently
expressing apoplast-targeted LTB or GFP were produced as
described previously [3]. Leaves were harvested at 7–10 days post-
infiltration, snap-frozen in liquid N2 then freeze-dried using
a Dynavac freeze drier (Model FD12) for 48 h with a maximum
shelf temperature of 20uC. Freeze-dried plant materials were
powdered using a commercial coffee grinder and sieved to
standardise particle size to 0.5–1 mm2. Accumulation of rLTB
pentamer, the functional form required for binding to GM1-
gangliosides on the mucosal surface of the gut epithelium, was
confirmed in N. bethamiana leaves and petunia hairy roots as per
[3]. In each case, the hairy root and leaf vaccine batches
accumulated 300 mg/g dwt rLTB.
Capture enzyme-linked immunosorbent assay (ELISA) to
determine rLTB in vaccine batches
Crude protein was extracted from freeze-dried plant material by
homogenising in 1:60 (w/v) PBST [PBS (137 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4, 2 mM KH2PO4) supplemented with
0.05% Tween 20] with two 3 mm tungsten carbide beads for
1 min at a frequency of 28/s in a Qiagen Mixer Mill. The
homogenate was cleared by centrifugation at 13,000 rpm at 4uC
for 5 min.
LTB-specific capture ELISA was performed using Costar 9018
96-well microtitre plates (Corning Life Sciences) coated with
50 ml/well of chicken anti-cholera enterotoxin subunit B (CTB)
antibody (Sigma-Aldrich) diluted 1:5,000 in PBS. Plates were
sealed and incubated at 4uC overnight. Unless stated otherwise, all
subsequent incubations were performed at 37uC for 1 h and
antibodies diluted in 1% dry skim milk powder (DM) in PBST.
Following all incubations, plates were washed three times with
PBST.
Plates were blocked with 5% DM in PBST before a 2 h room
temperature (22–25uC) incubation with serially diluted crude plant
extract starting with 1:100 in PBS. Plates were then incubated with
1:2,000 rabbit anti-LTB (Benchmark Biolabs), then 1:15,000 goat
anti-rabbit IgG HRP conjugate (Sigma-Aldrich). Bound LTB-
specific antibodies were visualised using TMB-peroxidase sub-
strate (Bio-Rad Laboratories) according to manufacturer’s instruc-
tions. The amount of rLTB in the freeze-dried plant materials was
calculated against a Pichia pastoris-made rLTB (Sigma-Aldrich)
Table 1. Oral immunisation treatments and number of sheep assigned to each group.
Treatment Sheep
Control hairy root (CtHR) 3 (Sheep #50, 28, 54)
Control leaf (CtLeaf) 2 (Sheep #37, 73)
Transgenic hairy root containing 5mg rLTB (LTB-HR) 5 (Sheep #29, 30, 31, 42, 75)
Transgenic leaf containing 5mg rLTB (LTB-Leaf) 5 (Sheep #36, 47, 57, 64, 69)
doi:10.1371/journal.pone.0052907.t001
Figure 1. LTB-specific IgG antibody titres in serum collected
from sheep before immunisation with LTB-Leaf (A), LTB-HR (B)
or control vaccines (C). Black symbols denote positive responders
defined as sheep with antibody titres at least three standard deviations
above the control mean, non-responders are indicated by grey symbols.
The horizontal lines represent geometric means, statistical analysis
(Student’s t-test determined a significant difference between the means
of the control and LTB-Leaf groups after four doses, p,0.05).
doi:10.1371/journal.pone.0052907.g001
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standard. Accumulation of the functional pentameric form of
rLTB was confirmed by western blot [3].
Mucosal vaccination of sheep
Outbred, male sheep (Ovis aries, Merion/Merino) aged between
4.5 to 12 months were obtained from the Commercial Registered
Pfizer Animal Health Woodend Farm and housed at the Monash
Figure 2. LTB-specific antibody titres in MLNs collected from successive sites along the small intestine of the sheep GIT following
oral immunisation with four doses of LTB-Leaf (A and D, IgG and IgA respectively), LTB-HR (B and E, IgG and IgA respectively) or
control (C and F, IgG and IgA respectively) plant materials. MLN 1 was sampled from the abomasum/duodenum junction, MLN 2–4 were the
next three lymph nodes sampled from the first 0.5 m of the small intestine. Black symbols denote positive responders defined as sheep with antibody
titres at least three standard deviations above the control mean, non-responders are indicated by grey symbols.
doi:10.1371/journal.pone.0052907.g002
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University Werribee Animal Facility under conditions approved
by the Monash University Animal Ethics Committee (AEC
SOBSA/P/2009/98). Sheep were provided with water and
standard feed ad lib and fasted 16 h before oral immunisation.
Sheep were randomly assigned into four groups of 2–5 animals
each (Table 1). A single sheep from the transgenic rLTB
expressing leaf vaccine group (LTB-Leaf) developed balanopsthitis
(pizzle rot) 14 days after beginning the trial and was treated with
a testosterone implant. This sheep was not excluded from analyses.
Sheep were immunised on days 0, 14 and 28 followed by a boost
dose on day 38, four days before sacrifice. Vaccine materials were
formulated immediately before delivery by mixing 19 g freeze-
dried plant material with 200 ml of an oil based emulsion (125 ml
peanut oil:75 ml dH2O). When receiving the transgenic rLTB
plant-based vaccines (LTB-HR or LTB-Leaf), each dose was
sufficient to deliver 5 mg rLTB. Sheep receiving the CtHR or
CtLeaf vaccines were immunised with the equivalent volume of
formulated control plant materials. The formulated vaccines were
administered orally to sheep by gavage directly into the rumen to
simulate drenching, a common delivery system used routinely to
worm domestic sheep flocks. At trial termination (day 42), sheep
were humanely killed by intravenous injection with a lethal dose of
lethobabarb (100 mg/kg bodyweight).
Collection and processing of biological specimens
Serum collection. Blood samples were taken from the
jugular vein using an 18 G needle immediately before the first
immunisation (pre-immune), 14 days after each of the first three
doses and four days (at trial termination) after the boost. The blood
was clotted at room temperature (20–22uC) overnight and serum
separated by centrifugation at 400 g for 10 min and stored at
220uC until required for LTB-specific antibody detection by
ELISA.
Sampling and in vitro culture of mesenteric lymph
nodes. At post-mortem, four lymph nodes were taken from
the mesentery, the first at the abomasum/duodenum junction
(MLN 1) and the next three along the first 0.5 m of the small
intestine (MLN 2–4). MLNs were subjected to an antigen-specific
antibody secreting cell (ASC) assay for detection of LTB-specific
antibody responses using a protocol modified from those pre-
viously described [23,24]. MLNs were dissected into small pieces
and cultured in 24-well flat-bottomed tissue culture plates. One
MLN and 1 ml complete DMEM medium (Gibco) containing
10% (v/v) heat-inactivated foetal calf serum (Thermo), 100 U/ml
penicillin (Gibco), 0.1 mg/ml streptomycin (Gibco) and 2 mM
glutamine (Gibco) per well were incubated at 37uC in a humidified
incubator with 5% CO2 for 24 h. Culture supernatants (ASC
supernatants) were collected and stored at 220uC and the
presence of LTB-specific antibodies determined by ELISA.
Sampling the mucosa of the abomasum. The mucosal
lining of the abomasum was sampled by scraping the inside surface
with a glass slide. Mucus scrapings were prepared for ELISA as
described by [25]. Abomasal scrapings were washed off the slide
into a 50 ml tube with 3 ml PBST supplemented with 2x Roche
Complete Protease Inhibitor Cocktail tablets (PBST2I). The
supernatant was collected following centrifugation at 9000 g for
15 min at 4uC and stored at 220uC until required.
Small intestine washes to sample intestinal
secretions. Four sections of the small intestine were excised,
each section measured 0.5 m in length and was taken 3 m apart,
beginning at the abomasum/duodenum junction (section 1, 0–
0.5 m). Sections 2–4 were sampled at 3.5–4 m, 7–7.5 m and 10.5–
11 m respectively. Each segment was flushed with 20 ml saline
then incubated for 30 min with 10 ml saline and gentle rocking.
Each end of the intestinal segments was clamped during washes to
prevent leakage. Washes containing intestinal secretions were
collected and stored at 220uC until required.
Faecal sampling. Faecal samples were collected before
vaccination on day 0 and again at day 16 and 36 h after
immunisation with the second oral dose allowing administered
vaccine material to complete transit through the sheep GIT [26].
Faecal matter was homogenised in 1 ml/g PBST2I with two
3 mm tungsten carbide beads for 1 min at a frequency of 28/s in
a Qiagen Mixer Mill. The homogenate was cleared by centrifu-
gation at 13,000 rpm at 4uC for 10 min and capture ELISA
performed (as described above) to detect and quantify LTB in the
supernatant.
ELISA to determine LTB-specific IgG and IgA antibody
titre
LTB-specific ELISA was used to assess IgG and IgA antibody
responses in immunised sheep. Costar 9018 96-well microtitre
plates (Corning Life Sciences) were coated with 50 ml/well chicken
CTB antibody (Sigma-Aldrich) diluted 1:5,000 in PBS. Plates were
Figure 3. LTB-specific IgG (A) and IgA (B) antibody titres in
abomasummucus following oral immunisation with four doses
of control or LTB-transgenic plant materials. The horizontal lines
represent geometric means. Black symbols denote positive responders
defined as sheep with antibody titres at least three standard deviations
above the control mean, non-responders are indicated by grey symbols.
doi:10.1371/journal.pone.0052907.g003
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sealed and incubated at 4uC overnight. Three washes with PBST
were performed following each incubation. Plates were blocked
with 5% DM in PBST at 37uC for 1 h before a further incubation
for 1 h at 37uC with 0.25 mg/ml Pichia-made rLTB (Sigma-
Aldrich). Serial dilutions of the various biological samples were
made on the plate with starting dilutions in PBST as follows –
1:1000 or undiluted serum for IgG or IgA determination
respectively, 1:2 ASC supernatant, 1:4 small intestine wash and
undiluted abomasum mucus. Plates were incubated overnight at
4uC before incubation with 1:2,000 mouse anti-sheep/goat IgG
HRP conjugate (Enzo Life Sciences), or rabbit anti-sheep IgA
HRP conjugate (Novus Biologicals) at 37uC for 2 h. Bound LTB-
specific antibodies were visualised using TMB-peroxidase sub-
strate (Bio-Rad Laboratories) according to manufacturer’s instruc-
tions. Endpoint antibody tire was reported as the highest dilution
with an absorbance of four standard deviation units above
background (mean absorbance of at least three wells lacking
biological sample). All measurements were performed in triplicate,
the geometric mean titre determined and data subjected to
statistical analysis using the non-parametic one way analysis of
variance (ANOVA) and student’s t-test. Data from sheep receiving
control vaccine treatments (CtHR and CtLeaf) were combined for
analysis. An antigen-specific antibody response exceeding the
geometric mean titre of the control group (background) by at least
three standard deviations was considered a positive response.
Results
Plant Materials
Two different plant species N. benthamiana and Petunia parodii
(petunia) were chosen due to their lack of use in the animal or
human food chain to reduce the chance of contamination of the
food chain and due to their ease of transformation. Although this
resulted in more than one variable in the study our previous study
demonstrated their optimal nature for oral delivery to mice [3]
and we hence sought to delineate their ability to orally deliver to
ruminants.
LTB-specific antibody responses in serum
Immunisation of sheep with the LTB-Leaf vaccine resulted in
a higher number of sheep with positive antigen-specific IgG-serum
responses than those receiving the LTB-HR vaccine (Fig. 1). The
mean titre observed for sheep immunised with the LTB-Leaf
vaccine was significantly different from controls after four vaccine
doses. In one of the five LTB-Leaf immunised sheep (Sheep #64),
the maximum IgG-serum response was observed after two
immunisations (Fig. 1A) and was not increased by an additional
two doses. After three doses, the number of reactive LTB-Leaf
immunised sheep was doubled, but this response waned in one
animal (Sheep #69) by trial’s end. In contrast, four doses of the
LTB-HR vaccine were required to produce a single animal (Sheep
#42) with reactive serum (Fig. 1B). LTB-specific IgA antibodies
were not detected in sera, irrespective of the vaccine or number of
doses administered. The baseline antibody titres observed in pre-
immune serum could be attributed to a low level of E. coli
colonisation in animals, which were not housed in germ-free
conditions.
LTB-specific antibody responses in antibody secreting
cells of mesenteric lymph nodes
Detection of antibody production in serum following oral
immunisation may not be indicative of immune responses at
mucosal sites [24]. The ASC assay was adopted as a potentially
more sensitive method for detection of antigen-specific antibody
production from MLNs draining the intestinal tissue. Unlike the
serum analysis, both IgG and IgA antibody isotypes were detected
in MLN-derived ASC supernatants taken from LTB-HR or LTB-
Leaf immunised sheep (Fig. 2).
All five sheep immunised with the LTB-Leaf vaccine assayed
positive for an LTB-specific ASC-IgG response at one or more of
the MLN sites sampled (Fig. 2A). One sheep from the LTB-Leaf
group (Sheep #57) exhibited a positive ASC-IgG response at all
Figure 4. LTB-specific antibody titres detected in intestinal washes performed at four sites along the first 11 m of the sheep small
intestine following oral immunisation with four doses of LTB-Leaf (A and D, IgG and IgA respectively), LTB-HR (B and E, IgG and IgA
respectively) or control (C and F, IgG and IgA respectively). Sections 1, 2, 3 and 4 are defined as the first 0–0.5 m, 3.5–4 m, 7–7.5 m and 10.5–
11 m respectively from the abomasum/duodenum junction. Black symbols denote positive responders defined as sheep with antibody titres at least
three standard deviations above the control mean, non-responders are indicated by grey symbols.
doi:10.1371/journal.pone.0052907.g004
Figure 5. Relative abundance of LTB-specific IgG (A) and IgA
(B) at different sections of the sheep small intestine following
oral immunisation with four doses of control or LTB-transgenic
plant materials. The horizontal lines represent geometric means.
Black symbols denote positive responders defined as sheep with
antibody titres at least three standard deviations above the control
mean, non-responders are indicated by grey symbols.
doi:10.1371/journal.pone.0052907.g005
Oral Immunogenicity of a Model PMV in Sheep
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four MLNs. This same sheep, along with Sheep #36 were also
positive for an ASC-IgA response at MLNs 1 and 2 respectively
(Fig. 2D). Of the LTB-HR immunised sheep, Sheep #42 and 31
displayed at least one positive ASC response for both IgG and IgA
isotypes with maximum IgA titres recorded for Sheep#42 at three
MLN sites (Fig. 2E).
LTB-specific antibody responses in the abomasal mucosa
and secretions of the small intestine
Induction of LTB-specific antibody responses in the mucosa of
the abomasum was identified only after immunisation with the
LTB-Leaf vaccine (Fig. 3). At this site three sheep were identified
as positive responders with IgA titres above those observed for the
control group (Fig. 3B). One of these sheep (Sheep #69) also
exhibited an elevated IgG titre (Fig. 3A).
LTB-specific IgG antibody was detected in intestinal washes of
two of the five sheep immunised with the LTB-Leaf vaccine
(Fig. 4A). In one of these sheep (Sheep #69) the response was
detected at all four sections sampled from the small intestine
(Fig. 4A). The number of antigen-specific IgG positive LTB-Leaf
immunised sheep increased from one to two when washes were
taken at sections 2 and 4 (3.5–4 m and 10.5–11 m respectively) of
the small intestine (Fig. 4A). It was at the most distant site sampled
that two IgG positive LTB-HR immunised sheep were also
identified (Fig. 4B). All sheep immunised with the LTB-Leaf
vaccine also exhibited a positive IgA response at one or more sites
sampled along the small intestine (Fig. 4D). LTB-specific IgA
responses in the small intestine were stimulated above controls in
two LTB-HR immunised sheep at all sections except section 3 (7–
7.5 m; Fig. 4E); one of these sheep (Sheep #75,) was also positive
at section 4 (10.5–11 m; Fig. 4E). Of the sites sampled along the
small intestine, the most immunologically responsive with respect
to immunoglobulin production was section 4 (10.5–11 m) for IgG
(Fig. 5A), whilst IgA was more widespread, observed at sections 2
to 4 (3.5–11 m; Fig. 5B).
Detection of LTB in faeces
Faecal samples were assayed for LTB to determine whether the
vaccine plant materials had resisted breakdown during passage
through the sheep GIT. LTB was not detected in faecal samples
taken from pre- and post-immune sheep from control, LTB-HR or
LTB-Leaf groups (data not shown).
Discussion
The pharmaceutical industry is constantly assessing methods for
improved delivery for vaccines, pharmaceuticals and nutraceu-
ticals. The oral route increases ease of delivery, is less expensive,
and encourages increased compliance by eliminating the need for
needles. Moreover, oral delivery is particularly desired for
immunising free-ranging domestic animals that are typically
ruminants. Numerous studies have reported immunogenicity of
orally delivered plant-made vaccines in humans and small animal
models, but few have demonstrated their efficacy in ruminants
[27,28,29,30]. We have previously determined that the way plant-
made vaccine material is delivered influences immunological
outcomes in mice [3]. We therefore now investigate how plant-
made vaccine material delivery influences immunological out-
comes in sheep, an important end user ruminant and also a model
for other ruminants such as goat and cattle.
LTB was chosen as our model antigen because it can be
produced in a wide variety of plant systems [3,16,19,20], is stable
under acidic conditions [31] and in the GIT [15] and has
immunogenic properties when delivered orally. Its affinity for
binding the GM1 receptor to mediate transepithelial flux from the
lumen into the abluminal environment also makes LTB a poten-
tially important component as an immune modulator in the design
of subunit vaccines. Similarly, the plant system used to orally
deliver a vaccine candidate merits careful consideration. De-
struction of pH-sensitive antigens in the acidic environment of the
sheep abomasum could be avoided if delivered from a root-based
vaccine to manipulate release into the small intestine. In the
present study, mucosal (abomasal, intestinal and ASC-derived IgA
and IgG) and systemic (serum IgG) immune responses were
achieved in sheep orally immunised with plant-made LTB
vaccines delivered from root and leaf material. Local antibody
detection at mucosal sites was more sensitive than serum. Of the
LTB-HR and LTB-Leaf vaccines delivered, the latter stimulated
more robust antigen-specific antibody responses at mucosal sites of
the GIT, including the stomach and small intestine, in serum and
MLNs.
Vaccine materials were formulated in oil and administered
directly into the rumen of the sheep via a tube inserted down the
oesophagus. The delivered plant materials were sieved to achieve
a uniform particle size of 0.5–1 mm2 to better protect the antigen
from degradation by minimising the time spent in the rumen. In
sheep, particles with diameters larger than 1.18 mm transit
through the rumen slower than smaller particles [32]; this has
also been found in cattle with increased forage particle size
improving fibre digestibility by increasing retention time in the
rumen [33].
From the rumen, the vaccine transits through the reticulum and
omasum before reaching the abomasum (true stomach) where
enzymatic digestion of protein, carbohydrates and lipids is
initiated. It is anticipated that breakdown of the plant cells
encapsulating the rLTB antigen begins in the rumen and
continues in the reticulum, the principal sites for cellulose digestion
in ruminant species. It was in the abomasum mucus that antibody
responses were first observed following administration of the LTB-
Leaf vaccine. This suggests that as the leaf material begins to
degrade the antigen remains sufficiently protected during rumi-
nation, presumably by the lipid coating provided by the oil
formulation matrix. In contrast, the lack of antibody response in
abomasum mucus from the LTB-HR vaccine suggests that root
tissue may be comparatively more resistant to rumination and
enzymatic digestion resulting in delayed antigen release.
Although GALT is absent in the abomasum, immune responses
can be induced when the mucosal epithelium is penetrated [2].
LTB is particularly efficient in crossing the epithelium from the
lumen primarily via binding to ganglioside GM1 along with other
mammalian galactoglycoprotein receptors [13,14]. Moreover,
direct sampling of antigen from the mucosal lumen may also
occur via intra- and sub-epithelial DCs [2,34]. Once the antigen
has traversed the mucosal epithelium it is transported by DCs via
the lymphatics to draining MLNs where antigen-specific B cells
are generated and then returned to mucosal sites via the blood
stream [2,35].
From the abomasum, the vaccine materials enter the small
intestine. By this stage breakdown of the plant cells and
formulation matrix should be completed, releasing the remainder
of its antigenic cargo. It was in the small intestine that the most
robust mucosal immune responses were detected from both the
LTB-Leaf and LTB-HR vaccines, the leaf material producing
elevated IgA titres compared to other treatments in all five sheep
receiving this vaccine. It was of interest that section 4, the section
further through the GIT, was the site where the most robust
antigen-specific IgG responses were found while IgA responses
expanded to earlier sites (sections 2 to 4). The consistency in the
Oral Immunogenicity of a Model PMV in Sheep
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immune response observed at the small intestine, particularly for
the LTB-Leaf group, is noteworthy given the potential for variable
responses when using an outbred sample of sheep.
LTB-specific IgA antibodies were absent in all sera, irrespective
of vaccine treatment or number of doses administered. This is not
unexpected as detection of antibody production in serum following
mucosal immunisation can be typically difficult particularly when
responses are low [24]. An alternative approach, previously
validated in several studies, was utilised to detect antibodies
secreted by MLNs using the ASC assay [23,36]. Elevated IgA
titres were detected in the MLNs of two LTB-Leaf- and LTB-HR-
vaccinated sheep as compared to other treatments. In addition,
MLN 2 was identified as the most active site for generating an IgG
response with all LTB-Leaf- (two more than that identified from
serum) and one LTB-HR-vaccinated sheep exhibiting stimulated
titres. It is interesting to note that the different plant vehicles
induced different isotype responses at the MLNs with root-
delivered LTB elevating IgA titres in contrast to the stimulated
IgG titres observed for the leaf-delivered counterpart.
Whilst most of the immune inductive sites of the GIT are
located in the GALT of the small intestine, the potency of the
LTB-Leaf vaccine benefitted from an early release in the
abomasum perhaps due to the stability of LTB and the resulting
prolonged antigen exposure at mucosal surfaces and priming distal
sites in the small intestine. Antibody responses at the tonsils or
other lymphoid tissues of the oral and nasopharyngeal cavities
were not sampled in this study but should not be discounted as
additional sites within the mucosal epithelium that could be
exploited for induction of immune responses from plant-made
vaccines. Plant material in its nature is fibrous and as such is often
regurgitated from the rumen during fermentation for further
mechanical breakdown by chewing and can result in repeated and
sustained exposure of the plant-delivered antigen to the tonsils
priming more distal sites of the GIT or respiratory system [28].
It is apparent that both the leaf- and root-based vaccine
preparations protected the antigenic load sufficiently during
rumination and enzymatic digestion to enable its delivery to
relevant immune responsive sites. Furthermore, the type of plant
tissue used can manipulate timing of antigen release. In our
experience, antigen release from both leaf- and root-based
vaccines has been consistent across sheep (present study) and
mouse [3] animal models. In each case the leaf-based vaccine
facilitated early antigen release in the true stomach of orally
immunised sheep and mice, whilst the root-based vaccine delayed
release to the small intestine. Improved antigen release and
antibody responses from root-based vaccine delivery vehicles may
be served by different plant species, altered culture conditions or
harvest times.
The plant material used to deliver LTB orally to sheep affected
immunogenicity. This finding suggests that a delicate balance
between protecting the vaccine antigen against digestive degrada-
tion and enabling release for presentation of the antigen at
immune responsive sites needs to be struck to maximise vaccine
efficacy. Although N. benthamiana leaf material provided the
optimal oral delivery vehicle for induction of mucosal immune
responses to LTB in both monogastric (mouse) and ruminant
(sheep) models, it is anticipated that plant choice will need to be
assessed on a case by case basis, taking into account antigen
stability.
Optimising oral delivery of plant-made, valuable proteins will
have broad ramifications to animal as well as human health. Oral
delivery will facilitate treatment of free-ranging domesticated and
native animal populations that may otherwise go untreated,
broaden opportunities for existing pharmaceuticals and create
opportunities for new compounds and target populations.
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